DOI: 10.1038/sj.cgt.7700302. Antitumor effect of B16 melanoma cells genetically modified with the angiogenesis inhibitor RNasin

Antitumor effect of B16 melanoma cells genetically modified with the angiogenesis inhibitor RNasin

10.1038/sj.cgt.7700302

Crossref journal-article

Springer Science and Business Media LLC

Cancer Gene Therapy (297)

Bibliography

Botella-Estrada, R., Malet, G., Revert, F., DasÃ, F., Crespo, A., SanmartÃn, O., GuillÃ©n, C., & AliÃ±o, S. F. (2001). Antitumor effect of B16 melanoma cells genetically modified with the angiogenesis inhibitor RNasin. Cancer Gene Therapy, 8(4), 278â284.

Authors 8

Rafael Botella-Estrada (first)
Gema Malet (additional)
Fernando Revert (additional)
Francisco Dasí (additional)
Antonio Crespo (additional)
Onofre Sanmartín (additional)
Carlos Guillén (additional)
Salvador F Aliño (additional)

References 27 Referenced 19

Folkman J, Hahnfeldt P, Hlatky L . The logic of antiangiogenic gene therapy In: Friedmann T, ed. The Development of Human Gene Therapy New York: Cold Spring Harbor Laboratory Press; 1999: 527–543
Boehm T, Folkman J, Bowden T, et al . Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 1997; 390:: 404–407 (10.1038/37126) / Nature by T Boehm (1997)
Millauer B, Shawver LK, Plate KH, et al . Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant Nature 1994; 367:: 576–579 (10.1038/367576a0) / Nature by B Millauer (1994)
Lin P, Buxton JA, Acheson A, et al . Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosinase kinase Tie2 Proc Natl Acad Sci USA 1998; 95:: 8829–8834 (10.1073/pnas.95.15.8829) / Proc Natl Acad Sci USA by P Lin (1998)
Goldman CK, Kendall RL, Cabrera G, et al . Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate Proc Natl Acad Sci USA 1998; 95:: 8795–8800 (10.1073/pnas.95.15.8795) / Proc Natl Acad Sci USA by CK Goldman (1998)
Guo N, Krutzsch HC, Inman JK, et al . Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells Cancer Res 1997; 57:: 1735–1742 / Cancer Res by N Guo (1997)
Dhanabal M, Ramchandran R, Waterman MJ, et al . Endostatin induces endothelial cell apoptosis J Biol Chem 1999; 274:: 11721–11726 (10.1074/jbc.274.17.11721) / J Biol Chem by M Dhanabal (1999)
Lucas R, Holmgren L, Garcia I, et al . Multiple forms of angiostatin induce apoptosis in endothelial cells Blood 1998; 92:: 4730–4741 (10.1182/blood.V92.10.3977) / Blood by R Lucas (1998)
Polakowski IJ, Lewis MK, Muthukkaruppan VR, et al . A ribonuclease inhibitor expresses antiangiogenic properties and leads to reduced tumor growth in mice Am J Pathol 1993; 143:: 507–517 / Am J Pathol by IJ Polakowski (1993)
Shapiro R, Vallee BL . Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin Proc Natl Acad Sci USA 1987; 84:: 2238–2241 (10.1073/pnas.84.8.2238) / Proc Natl Acad Sci USA by R Shapiro (1987)
O'Reilly MS, Holmgren L, Shing Y, et al . Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 1994; 79:: 315–328 (10.1016/0092-8674(94)90200-3) / Cell by MS O'Reilly (1994)
O'Reilly MS, Boehm T, Shing Y, et al . Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 1997; 88:: 277–285 (10.1016/S0092-8674(00)81848-6) / Cell by MS O'Reilly (1997)
Cao Y, O'Reilly MS, Marshall B, et al . Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases J Clin Invest 1998; 101:: 1055–1063 (10.1172/JCI1558) / J Clin Invest by Y Cao (1998)
Vlodavsky I, Korner G, Ishai-Michaeli P, et al . Extracellular matrix–resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis Cancer Metastasis Rev 1990; 9:: 203–226 (10.1007/BF00046361) / Cancer Metastasis Rev by I Vlodavsky (1990)
Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K, et al . Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis Cancer Res 1994; 54:: 6504–6511 / Cancer Res by DL Weinstat-Saslow (1994)
Hannahan D, Folkman J . Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 1996; 86:: 353–364 (10.1016/S0092-8674(00)80108-7) / Cell by D Hannahan (1996)
Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other diseases Nat Med 1995; 1:: 27–31 (10.1038/nm0195-27) / Nat Med by J Folkman (1995)
Fidler IJ, Ellis LM . The implications of angiogenesis for the biology and therapy of cancer metastasis Cell 1994; 79:: 185–188 (10.1016/0092-8674(94)90187-2) / Cell by IJ Fidler (1994)
Papageorgiou AC, Shapiro R, Acharya KR . Molecular recognition of human angiogenin by placental ribonuclease inhibitor — an X-ray crystallographic study at 2.0 Å resolution EMBO J 1997; 16:: 5162–5177 (10.1093/emboj/16.17.5162) / EMBO J by AC Papageorgiou (1997)
Fett JW, Strydom DJ, Lobb RR, et al . Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells Biochemistry 1985; 24:: 5480–5486 (10.1021/bi00341a030) / Biochemistry by JW Fett (1985)
Strydom DJ, Fett JW, Lobb RR, et al . Amino acid sequence of human tumor–derived angiogenin Biochemistry 1985; 24:: 5486–5494 (10.1021/bi00341a031) / Biochemistry by DJ Strydom (1985)
Kurachi K, Davie EW, Strydom DJ, et al . Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor Biochemistry 1985; 24:: 5494–5499 (10.1021/bi00341a032) / Biochemistry by K Kurachi (1985)
Shapiro R, Weremowicz S, Riordan JF, et al . Ribonucleolytic activity of angiogenin: essential histidine, lysine, and arginine residues Proc Natl Acad Sci USA 1987; 84:: 8783–8787 (10.1073/pnas.84.24.8783) / Proc Natl Acad Sci USA by R Shapiro (1987)
Shapiro R, Fox EA, Riordan JF . Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis Biochemistry 1989; 28:: 1726–1732 (10.1021/bi00430a045) / Biochemistry by R Shapiro (1989)
Shapiro R, Vallee BL . Site-directed mutagenesis of histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis Biochemistry 1989; 28:: 7401–7408 (10.1021/bi00444a038) / Biochemistry by R Shapiro (1989)
Harper JW, Vallee BL . Mutagenesis of aspartic acid-116 enhances the ribonucleolytic activity and angiogenic potency of angiogenin Proc Natl Acad Sci USA 1988; 85:: 7139–7143 (10.1073/pnas.85.19.7139) / Proc Natl Acad Sci USA by JW Harper (1988)
Hallahan TW, Shapiro R, Vallee BL . Dual-site model for the organogenic activity of angiogenin Proc Natl Acad Sci USA 1991; 82:: 2222–2226 (10.1073/pnas.88.6.2222) / Proc Natl Acad Sci USA by TW Hallahan (1991)

Dates

Type	When
Created	22 years, 11 months ago (Sept. 17, 2002, 2:09 p.m.)
Deposited	3 years, 5 months ago (March 22, 2022, 9:25 a.m.)
Indexed	1 year, 7 months ago (Jan. 26, 2024, 3:16 a.m.)
Issued	24 years, 5 months ago (April 1, 2001)
Published	24 years, 5 months ago (April 1, 2001)
Published Online	24 years, 2 months ago (June 22, 2001)
Published Print	24 years, 5 months ago (April 1, 2001)

Funders 0

None

BibTeX

@article{Botella_Estrada_2001, title={Antitumor effect of B16 melanoma cells genetically modified with the angiogenesis inhibitor RNasin}, volume={8}, ISSN={1476-5500}, url={http://dx.doi.org/10.1038/sj.cgt.7700302}, DOI={10.1038/sj.cgt.7700302}, number={4}, journal={Cancer Gene Therapy}, publisher={Springer Science and Business Media LLC}, author={Botella-Estrada, Rafael and Malet, Gema and Revert, Fernando and Dasí, Francisco and Crespo, Antonio and Sanmartín, Onofre and Guillén, Carlos and Aliño, Salvador F}, year={2001}, month=apr, pages={278–284} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2024,
        1,
        26
      ]
    ],
    "date-time": "2024-01-26T08:16:55Z",
    "timestamp": 1706257015600
  },
  "reference-count": 27,
  "publisher": "Springer Science and Business Media LLC",
  "issue": "4",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2001,
            4,
            1
          ]
        ],
        "date-time": "2001-04-01T00:00:00Z",
        "timestamp": 986083200000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.springer.com/tdm"
    },
    {
      "start": {
        "date-parts": [
          [
            2001,
            4,
            1
          ]
        ],
        "date-time": "2001-04-01T00:00:00Z",
        "timestamp": 986083200000
      },
      "content-version": "vor",
      "delay-in-days": 0,
      "URL": "https://www.springer.com/tdm"
    }
  ],
  "content-domain": {
    "domain": [
      "link.springer.com"
    ],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2001,
        4,
        1
      ]
    ]
  },
  "DOI": "10.1038/sj.cgt.7700302",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        9,
        17
      ]
    ],
    "date-time": "2002-09-17T18:09:05Z",
    "timestamp": 1032286145000
  },
  "page": "278-284",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "source": "Crossref",
  "is-referenced-by-count": 19,
  "title": "Antitumor effect of B16 melanoma cells genetically modified with the angiogenesis inhibitor RNasin",
  "prefix": "10.1038",
  "volume": "8",
  "author": [
    {
      "given": "Rafael",
      "family": "Botella-Estrada",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Gema",
      "family": "Malet",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Fernando",
      "family": "Revert",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Francisco",
      "family": "Das\u00ed",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Antonio",
      "family": "Crespo",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Onofre",
      "family": "Sanmart\u00edn",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Carlos",
      "family": "Guill\u00e9n",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Salvador F",
      "family": "Ali\u00f1o",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "published-online": {
    "date-parts": [
      [
        2001,
        6,
        22
      ]
    ]
  },
  "reference": [
    {
      "key": "BF7700302_CR1",
      "unstructured": "Folkman J, Hahnfeldt P, Hlatky L . The logic of antiangiogenic gene therapy In: Friedmann T, ed. The Development of Human Gene Therapy New York: Cold Spring Harbor Laboratory Press; 1999: 527\u2013543"
    },
    {
      "key": "BF7700302_CR2",
      "doi-asserted-by": "publisher",
      "first-page": "404",
      "DOI": "10.1038/37126",
      "volume": "390:",
      "author": "T Boehm",
      "year": "1997",
      "unstructured": "Boehm T, Folkman J, Bowden T, et al . Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 1997; 390:: 404\u2013407",
      "journal-title": "Nature"
    },
    {
      "key": "BF7700302_CR3",
      "doi-asserted-by": "publisher",
      "first-page": "576",
      "DOI": "10.1038/367576a0",
      "volume": "367:",
      "author": "B Millauer",
      "year": "1994",
      "unstructured": "Millauer B, Shawver LK, Plate KH, et al . Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant Nature 1994; 367:: 576\u2013579",
      "journal-title": "Nature"
    },
    {
      "key": "BF7700302_CR4",
      "doi-asserted-by": "publisher",
      "first-page": "8829",
      "DOI": "10.1073/pnas.95.15.8829",
      "volume": "95:",
      "author": "P Lin",
      "year": "1998",
      "unstructured": "Lin P, Buxton JA, Acheson A, et al . Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosinase kinase Tie2 Proc Natl Acad Sci USA 1998; 95:: 8829\u20138834",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "BF7700302_CR5",
      "doi-asserted-by": "publisher",
      "first-page": "8795",
      "DOI": "10.1073/pnas.95.15.8795",
      "volume": "95:",
      "author": "CK Goldman",
      "year": "1998",
      "unstructured": "Goldman CK, Kendall RL, Cabrera G, et al . Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate Proc Natl Acad Sci USA 1998; 95:: 8795\u20138800",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "BF7700302_CR6",
      "first-page": "1735",
      "volume": "57:",
      "author": "N Guo",
      "year": "1997",
      "unstructured": "Guo N, Krutzsch HC, Inman JK, et al . Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells Cancer Res 1997; 57:: 1735\u20131742",
      "journal-title": "Cancer Res"
    },
    {
      "key": "BF7700302_CR7",
      "doi-asserted-by": "publisher",
      "first-page": "11721",
      "DOI": "10.1074/jbc.274.17.11721",
      "volume": "274:",
      "author": "M Dhanabal",
      "year": "1999",
      "unstructured": "Dhanabal M, Ramchandran R, Waterman MJ, et al . Endostatin induces endothelial cell apoptosis J Biol Chem 1999; 274:: 11721\u201311726",
      "journal-title": "J Biol Chem"
    },
    {
      "key": "BF7700302_CR8",
      "doi-asserted-by": "crossref",
      "first-page": "4730",
      "DOI": "10.1182/blood.V92.10.3977",
      "volume": "92:",
      "author": "R Lucas",
      "year": "1998",
      "unstructured": "Lucas R, Holmgren L, Garcia I, et al . Multiple forms of angiostatin induce apoptosis in endothelial cells Blood 1998; 92:: 4730\u20134741",
      "journal-title": "Blood"
    },
    {
      "key": "BF7700302_CR9",
      "first-page": "507",
      "volume": "143:",
      "author": "IJ Polakowski",
      "year": "1993",
      "unstructured": "Polakowski IJ, Lewis MK, Muthukkaruppan VR, et al . A ribonuclease inhibitor expresses antiangiogenic properties and leads to reduced tumor growth in mice Am J Pathol 1993; 143:: 507\u2013517",
      "journal-title": "Am J Pathol"
    },
    {
      "key": "BF7700302_CR10",
      "doi-asserted-by": "publisher",
      "first-page": "2238",
      "DOI": "10.1073/pnas.84.8.2238",
      "volume": "84:",
      "author": "R Shapiro",
      "year": "1987",
      "unstructured": "Shapiro R, Vallee BL . Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin Proc Natl Acad Sci USA 1987; 84:: 2238\u20132241",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "BF7700302_CR11",
      "doi-asserted-by": "publisher",
      "first-page": "315",
      "DOI": "10.1016/0092-8674(94)90200-3",
      "volume": "79:",
      "author": "MS O'Reilly",
      "year": "1994",
      "unstructured": "O'Reilly MS, Holmgren L, Shing Y, et al . Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 1994; 79:: 315\u2013328",
      "journal-title": "Cell"
    },
    {
      "key": "BF7700302_CR12",
      "doi-asserted-by": "publisher",
      "first-page": "277",
      "DOI": "10.1016/S0092-8674(00)81848-6",
      "volume": "88:",
      "author": "MS O'Reilly",
      "year": "1997",
      "unstructured": "O'Reilly MS, Boehm T, Shing Y, et al . Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 1997; 88:: 277\u2013285",
      "journal-title": "Cell"
    },
    {
      "key": "BF7700302_CR13",
      "doi-asserted-by": "publisher",
      "first-page": "1055",
      "DOI": "10.1172/JCI1558",
      "volume": "101:",
      "author": "Y Cao",
      "year": "1998",
      "unstructured": "Cao Y, O'Reilly MS, Marshall B, et al . Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases J Clin Invest 1998; 101:: 1055\u20131063",
      "journal-title": "J Clin Invest"
    },
    {
      "key": "BF7700302_CR14",
      "doi-asserted-by": "publisher",
      "first-page": "203",
      "DOI": "10.1007/BF00046361",
      "volume": "9:",
      "author": "I Vlodavsky",
      "year": "1990",
      "unstructured": "Vlodavsky I, Korner G, Ishai-Michaeli P, et al . Extracellular matrix\u2013resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis Cancer Metastasis Rev 1990; 9:: 203\u2013226",
      "journal-title": "Cancer Metastasis Rev"
    },
    {
      "key": "BF7700302_CR15",
      "first-page": "6504",
      "volume": "54:",
      "author": "DL Weinstat-Saslow",
      "year": "1994",
      "unstructured": "Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K, et al . Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis Cancer Res 1994; 54:: 6504\u20136511",
      "journal-title": "Cancer Res"
    },
    {
      "key": "BF7700302_CR16",
      "doi-asserted-by": "publisher",
      "first-page": "353",
      "DOI": "10.1016/S0092-8674(00)80108-7",
      "volume": "86:",
      "author": "D Hannahan",
      "year": "1996",
      "unstructured": "Hannahan D, Folkman J . Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 1996; 86:: 353\u2013364",
      "journal-title": "Cell"
    },
    {
      "key": "BF7700302_CR17",
      "doi-asserted-by": "publisher",
      "first-page": "27",
      "DOI": "10.1038/nm0195-27",
      "volume": "1:",
      "author": "J Folkman",
      "year": "1995",
      "unstructured": "Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other diseases Nat Med 1995; 1:: 27\u201331",
      "journal-title": "Nat Med"
    },
    {
      "key": "BF7700302_CR18",
      "doi-asserted-by": "publisher",
      "first-page": "185",
      "DOI": "10.1016/0092-8674(94)90187-2",
      "volume": "79:",
      "author": "IJ Fidler",
      "year": "1994",
      "unstructured": "Fidler IJ, Ellis LM . The implications of angiogenesis for the biology and therapy of cancer metastasis Cell 1994; 79:: 185\u2013188",
      "journal-title": "Cell"
    },
    {
      "key": "BF7700302_CR19",
      "doi-asserted-by": "publisher",
      "first-page": "5162",
      "DOI": "10.1093/emboj/16.17.5162",
      "volume": "16:",
      "author": "AC Papageorgiou",
      "year": "1997",
      "unstructured": "Papageorgiou AC, Shapiro R, Acharya KR . Molecular recognition of human angiogenin by placental ribonuclease inhibitor \u2014 an X-ray crystallographic study at 2.0 \u00c5 resolution EMBO J 1997; 16:: 5162\u20135177",
      "journal-title": "EMBO J"
    },
    {
      "key": "BF7700302_CR20",
      "doi-asserted-by": "publisher",
      "first-page": "5480",
      "DOI": "10.1021/bi00341a030",
      "volume": "24:",
      "author": "JW Fett",
      "year": "1985",
      "unstructured": "Fett JW, Strydom DJ, Lobb RR, et al . Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells Biochemistry 1985; 24:: 5480\u20135486",
      "journal-title": "Biochemistry"
    },
    {
      "key": "BF7700302_CR21",
      "doi-asserted-by": "publisher",
      "first-page": "5486",
      "DOI": "10.1021/bi00341a031",
      "volume": "24:",
      "author": "DJ Strydom",
      "year": "1985",
      "unstructured": "Strydom DJ, Fett JW, Lobb RR, et al . Amino acid sequence of human tumor\u2013derived angiogenin Biochemistry 1985; 24:: 5486\u20135494",
      "journal-title": "Biochemistry"
    },
    {
      "key": "BF7700302_CR22",
      "doi-asserted-by": "publisher",
      "first-page": "5494",
      "DOI": "10.1021/bi00341a032",
      "volume": "24:",
      "author": "K Kurachi",
      "year": "1985",
      "unstructured": "Kurachi K, Davie EW, Strydom DJ, et al . Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor Biochemistry 1985; 24:: 5494\u20135499",
      "journal-title": "Biochemistry"
    },
    {
      "key": "BF7700302_CR23",
      "doi-asserted-by": "publisher",
      "first-page": "8783",
      "DOI": "10.1073/pnas.84.24.8783",
      "volume": "84:",
      "author": "R Shapiro",
      "year": "1987",
      "unstructured": "Shapiro R, Weremowicz S, Riordan JF, et al . Ribonucleolytic activity of angiogenin: essential histidine, lysine, and arginine residues Proc Natl Acad Sci USA 1987; 84:: 8783\u20138787",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "BF7700302_CR24",
      "doi-asserted-by": "publisher",
      "first-page": "1726",
      "DOI": "10.1021/bi00430a045",
      "volume": "28:",
      "author": "R Shapiro",
      "year": "1989",
      "unstructured": "Shapiro R, Fox EA, Riordan JF . Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis Biochemistry 1989; 28:: 1726\u20131732",
      "journal-title": "Biochemistry"
    },
    {
      "key": "BF7700302_CR25",
      "doi-asserted-by": "publisher",
      "first-page": "7401",
      "DOI": "10.1021/bi00444a038",
      "volume": "28:",
      "author": "R Shapiro",
      "year": "1989",
      "unstructured": "Shapiro R, Vallee BL . Site-directed mutagenesis of histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis Biochemistry 1989; 28:: 7401\u20137408",
      "journal-title": "Biochemistry"
    },
    {
      "key": "BF7700302_CR26",
      "doi-asserted-by": "publisher",
      "first-page": "7139",
      "DOI": "10.1073/pnas.85.19.7139",
      "volume": "85:",
      "author": "JW Harper",
      "year": "1988",
      "unstructured": "Harper JW, Vallee BL . Mutagenesis of aspartic acid-116 enhances the ribonucleolytic activity and angiogenic potency of angiogenin Proc Natl Acad Sci USA 1988; 85:: 7139\u20137143",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "BF7700302_CR27",
      "doi-asserted-by": "publisher",
      "first-page": "2222",
      "DOI": "10.1073/pnas.88.6.2222",
      "volume": "82:",
      "author": "TW Hallahan",
      "year": "1991",
      "unstructured": "Hallahan TW, Shapiro R, Vallee BL . Dual-site model for the organogenic activity of angiogenin Proc Natl Acad Sci USA 1991; 82:: 2222\u20132226",
      "journal-title": "Proc Natl Acad Sci USA"
    }
  ],
  "container-title": "Cancer Gene Therapy",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://www.nature.com/articles/7700302.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/7700302",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/7700302.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2022,
        3,
        22
      ]
    ],
    "date-time": "2022-03-22T13:25:09Z",
    "timestamp": 1647955509000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/7700302"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2001,
        4,
        1
      ]
    ]
  },
  "references-count": 27,
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2001,
          4,
          1
        ]
      ]
    }
  },
  "alternative-id": [
    "BF7700302"
  ],
  "URL": "http://dx.doi.org/10.1038/sj.cgt.7700302",
  "relation": {},
  "ISSN": [
    "0929-1903",
    "1476-5500"
  ],
  "subject": [],
  "container-title-short": "Cancer Gene Ther",
  "published": {
    "date-parts": [
      [
        2001,
        4,
        1
      ]
    ]
  },
  "assertion": [
    {
      "value": "22 June 2001",
      "order": 1,
      "name": "first_online",
      "label": "First Online",
      "group": {
        "name": "ArticleHistory",
        "label": "Article History"
      }
    }
  ]
}